CATO SMS has rebranded and became Allucent to emphasize the company’s spotlight on serving the specialized needs of small and mid-sized biotech companies.
The new name and branding come after a series of strategic acquisitions, most recently Pharm-Olam, that doubled the company’s size.
In three short years, we’ve transformed our company to meet the unique needs of small and mid-sized biotechs. Our new name, Allucent, puts the focus on the clients we exist to serve and aligns our people under our shared passion of helping to bring new therapies to light. As we continue our growth journey, we’re committed to making sure we remain big enough to deliver, but small enough to care.
Mark Goldberg, M.D., Chairman and CEO, Allucent
Derived from the Latin verb alluceo, Allucent means to shine a light upon something or create an opportunity.